A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
Status:
Recruiting
Trial end date:
2029-01-16
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety, tolerability, and preliminary efficacy of
BMS-986460 in men with Metastatic Castration-resistant Prostate Cancer.